Why the study?
Timely diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) remains challenging, and although guidelines recommend assessing for red flags to facilitate detection, their diagnostic validation in patients with left ventricular thickening remains incomplete.
Population
425 patients with left ventricular thickening (321 ATTR-CM, 104 control group) at a tertiary amyloidosis center
Comparison
321 patients with ATTR-CM vs 104 control group patients
Design
Prospective registry study
Answers are grounded in this paper and cite their sources.
May aid ATTR-CM detection in LV thickening; leaves open need for prospective validation before practice change.
INTRODUCTION: Timely diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) is critical to improving outcomes and remains challenging. Guidelines recommend assessing for red flags (RFs) to facilitate ATTR-CM detection, but their diagnostic validation remains incomplete. This study aimed to multidimensionally validate these RFs in patients with left ventricular thickening (LVT). METHODS: Prospective registry study including all patients with LVT and standardized workup at tertiary amyloidosis center. For validated RFs, "high-risk" (specificity for ATTR-CM>90%) and "low-risk" (false-negative rate<5%) findings were predefined. RESULTS: 425 patients (321 ATTR-CM,104 control group) were included. Heart failure (97%) and polyneuropathies (78%) were among most sensitive clinical findings, while bilateral carpal tunnel syndrome (bCTS) was more specific (80%) but less sensitive (45%). Diverse ECG changes were common, yet mostly unspecific. Marked elevations of NT-proBNP and troponin were most discriminative among non-imaging RFs (Youden's index[YI]:59%). Apical sparing (Apical-to-Basal-strain-ratio≥2.0) was the most effective, stage-independent echocardiographic parameter (YI62%), followed by biatrial enlargement, advanced diastolic dysfunction, and LVGLS impairment (YI48-55%). Normal ECG without conduction disorders history and normal levels of both NT-proBNP and hs-troponin-T constituted "low-risk" findings. Heart failure with concomitant bCTS, peripheral low voltage, right ventricular dysfunction, 5-5-5 sign, restrictive filling pattern and apical sparing with LVGLS impairment represented "high-risk" RFs. Contrary to most non-imaging RFs, most echocardiographic RFs showed association with advancing disease stage (p<0.05). All aforementioned RFs were associated with ATTR-CM independently of age, sex, and LVT-severity (p<0.05). CONCLUSIONS: ATTR-CM is frequently associated with validated RFs that differ in their diagnostic characteristics, which should be considered when evaluating for ATTR-CM.
No takes yet. Share an insight, caveat, or question.
Piwowarski et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: